Webinar Date: Tuesday, December 19, 2023 – 06:00 PM
Thrombotic thrombocytopenic purpura (TTP) is a medical emergency with a high mortality rate if not treated. The cornerstone of treatment for TTP is therapeutic plasma exchange (TPE) with plasma replacement. This presentation will discuss how the approval of caplacizumab will change the TTP treatment paradigm.
Level: Advanced
Brian Carney, MD
Medical Director of Apheresis Services
Beth Israel Deaconess Medical Center
This webinar is approved for 1.0 credit hours by the ASCLS P.A.C.E. ® Program.
To view a recording of this webinar please click below and enter passcode: hZ%@=6gX